Saudi Arabia Medical Devices Market Size, Share & Industry Analysis, By Type (Orthopedic Devices, Cardiovascular Devices, Diagnostic Imaging, In-vitro Diagnostics (IVD), Minimally Invasive Surgery (MIS), Wound Management, Diabetes Care, Ophthalmic Devices, Dental Devices, Nephrology Devices, General Surgery, and Others), By End User (Hospitals & ASCs, Clinics, and Others), and Forecast, 2025-2032

The Saudi Arabia medical devices market size was valued at USD 6.07 billion in 2024. The market is projected to grow from USD 6.38 billion in 2025 to USD 9.03 billion by 2032, exhibiting a CAGR of 5.1% during the forecast period.

Medical devices are the medical equipment used for the diagnosis and treatment of chronic conditions. The growing burden of chronic diseases such as cancer, neurological disorders, diabetes, etc., has been fueling the demand for medical diagnosis and treatment devices.

• For instance, as per the data published by the World Health Organization (WHO) in 2022, around 28,113 new cancer cases were observed in Saudi Arabia, and around 94,951 prevalent cancer cases in the past 5 years. Breast cancer was among the most prevalent conditions among women, affecting around 3,777 women in Saudi Arabia in 2022.

Key players such as Medtronic, Johnson & Johnson, and Stryker have been focusing on partnerships and new product launches with an aim to fuel their revenue growth.

Market Dynamics

Market Drivers

Growing Burden of Chronic Diseases and Accidents has been Fueling the Market Growth

High burden of chronic diseases such as Alzheimer’s, diabetes, cardiac disorders, etc., has been fueling the demand for medical equipment for treatment and diagnosis.

• For instance, as per the data published by BioMed Central Ltd in March 2024, cardiovascular diseases (CVD) affected around 1.6% of the total population in Saudi Arabia. The prevalence of CVD in males was around 1.9% and in females, the prevalence was around 1.4%.

Moreover, the high burden of accidental injuries has also been fueling the demand for surgical devices for the treatment.

• For instance, as per the data published by the World Health Organization (WHO) in 2023, the fatality rate due to road accidents was 28.8 per 100,000 people.

Therefore, the growing demand for medical equipment due to the high burden of chronic diseases and road accidents has been fueling the market growth.

Market Restraints

Limited Availability of Skilled Healthcare Professionals Limits the Market Growth 

The high burden of chronic conditions has been fueling the demand for advanced devices in the country. However, certain medical devices that have complex operations require skilled professionals for their operation.

The shortage of skilled professionals limits the adoption of these complex devices. For instance, as per the data published by the Saudi Arabian General Investment Authority (SAGIA) in 2023, the country has a deficit of around 15,000 doctors and 20,000 nurses in Saudi Arabia.

Moreover, the poor healthcare infrastructure in rural areas also limits the adoption of advanced devices in these facilities.

Therefore, the limited penetration of advanced devices in the country due to the shortage of skilled workforce and poor healthcare infrastructure has been restricting the market growth.

Market Opportunities

Increasing Focus of the Market Players on Conducting Clinical Trials is Expected to Create Opportunities for Market Growth

Market players have been focusing on conducting clinical trials in the country with an aim to enhance their product portfolio.

• For instance, AbbVie initiated a phase 3 clinical trial in June 2024 to study the safety and efficacy of Lutikizumab administered through prefilled syringes in patients suffering from hidradenitis suppurativa. The expected completion date of the study is in December 2026. The study was conducted in 242 locations globally; out of these locations, two were in Saudi Arabia.

The increasing focus of the market players in conducting clinical trials in the country on novel medical equipment has been fueling the market growth.

Market Challenges

Complex Regulatory Scenarios and High Development Costs Limit the Market Growth

The medical imaging equipment is facing significant challenges due to stringent and complex regulations imposed by regional and international authorities. Obtaining product approvals from bodies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), or equivalent local regulators involves lengthy evaluation processes, high compliance costs, and rigorous safety and efficacy requirements.

These challenges are delaying the entry of innovative products into the market as well as increasing the financial burden on manufacturers. Furthermore, the high cost of developing advanced imaging equipment, driven by expensive raw materials, R&D investments, and integration of AI-based technologies, is posing difficulties for smaller companies to compete with larger, established players. This is expected to limit the product availability and ultimately challenge the Saudi Arabia medical devices market growth.

Request a Free sample to learn more about this report.

Medical Devices Market Trends

Market Players Have Increased their Emphasis on New Product Launches

Market players have been focusing on the commercialization of advanced products in the country to strengthen their brand presence.

• For instance, in February 2024, Koninklijke Philips N.V. launched Zenition 90 motorized, an image-guided therapy mobile C-arm system globally.

Furthermore, market players have also been focusing on enhancing the features of their available products to increase their products’ efficiency.

• For instance, in September 2024, F. Hoffmann-La Roche Ltd announced that it expanded the digital pathology open environment with the addition of 20 artificial intelligence (AI) algorithms with the help of 8 new collaborators. With this strategic initiative, the company aimed to enhance cancer diagnosis and research.

Segmentation Analysis

By Type

In-Vitro Diagnostics Segment Dominated The Market Due To Early Detection And Monitoring Of Medical Conditions

By type, the market is classified into orthopedic devices, wound management, cardiovascular devices, diagnostic imaging, in-vitro diagnostics, minimally invasive surgery (MIS), diabetes care, nephrology, ophthalmic, dental, nephrology, general surgery, and others.

The in-vitro diagnostics segment accounted for the largest market share in 2024. Saudi Arabia is increasingly investing in high-throughput platforms, molecular diagnostics, point-of-care (POC) testing, and screening programs due to rising demand for early detection and monitoring of certain medical conditions, including cancer, and others. This is expected to favor the utilization of IVD products, such as biochemical assays, hematology, and immunoassays, thereby contributing to the segment’s growth.

 The others segment held the second highest due to the growing prevalence of neurological disorders in the country, which has been fueling the demand for effective diagnosis and treatment options.

• For instance, as per the data published by the National Center for Biotechnology Information (NCBI), in 2022, the prevalence of mild cognitive impairment (MCI) was 38.6% and dementia was 6.4% in Saudi Arabia.

Moreover, the dental segment is expected to grow at the fastest CAGR during the forecast period. The segment’s growth is attributed to the growing burden of dental malocclusion in the country and increasing awareness regarding effective treatment options.

To know how our report can help streamline your business, Speak to Analyst

By End User

Increasing Patients’ Preference Towards Hospital & ASCs Visits for Diagnosis and Treatment of Diseases is Responsible Segment’s Dominance

By end user, the market is segmented into hospitals & ASCs, clinics, and others.

The hospitals & ASCs segment dominated the market in 2024 due to the increasing prevalence of chronic disorders, accidental injuries, etc. Moreover, increasing preference of patients to visit hospitals for the treatment and diagnosis of diseases is responsible for the segment’s growth in the country. 

The clinics segment is anticipated to grow at the highest CAGR during the forecast period due to the increasing number of healthcare professionals opening their private specialty clinics in the country.

Competitive Landscape

Key Market Players

Market Players Emphasis Creating Awareness Regarding their Products

Market players such as Johnson & Johnson, GE Healthcare, Medtronic, and Stryker are among the key players accounting for a significant portion of the Saudi Arabia medical devices market share. The increasing focus of these market players on creating awareness regarding their products is responsible for their strong presence.

• For instance, in April 2023, Medtronic demonstrated that its product MiniMed 780G system can effectively diagnose people living with diabetes, irrespective of any region across the globe.

Other players, such as Koninklijke Philips N.V., Abbott, Siemens Healthineers AG, BD, and Cardinal Health, are focusing on new product launches with an aim to strengthen their product portfolio.

LIST OF KEY SAUDI ARABIA MEDICAL DEVICES COMPANIES PROFILED

• Medtronic (Ireland)
• Johnson & Johnson (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Hoffmann-La Roche Ltd. (Switzerland)
• Boston Scientific Corporation (U.S.)
• Fresenius Medical Care AG (Saudi Arabia)
• GE Healthcare (U.S.)
• Siemens Healthineers AG (Saudi Arabia)
• Stryker (U.S.)
• Abbott (U.S.)
• BD (U.S.)
• Cardinal Health (U.S.)

KEY INDUSTRY DEVELOPMENTS

• June 2025 – Johnson & Johnson launched the ACUVUE OASYS MAX 1-Day MULTIFOCAL, disposable contact lenses indicated for astigmatism.
• June 2025 – Johnson & Johnson announced the commercialization of its TECNIS Odyssey IOL in Europe, the Middle East, and Canada, with an aim to expand its product portfolio for presbyopia-correcting intraocular lenses (PC - IOL).
• May 2025 – Medtronic announced that it has separated its diabetes business segment into a standalone company.
• May 2025 – BD announced the global launch of the BD FACSDiscover A8 cell analyzer. It is the first cell analyzer including spectral and real-time cell imaging technologies.
• April 2025 – Medtronic announced that its Affera pulsed field ablation technologies have been giving promising clinical outcomes from clinical studies for atrial fibrillation (AFib) patients.

REPORT COVERAGE

To gain extensive insights into the market, Request for Customization

Report Scope & Segmentation